Newer antidepressants are needed for the many individuals with major depressive disorder (MDD) that do not respond adequately to treatment and because of a delay of weeks before the emergence of therapeutic effects. Recent evidence from clinical trials shows that the NMDA antagonist ketamine is a revolutionary novel antidepressant because it acts rapidly and is effective for treatment-resistant patients.
Popular Blog Posts
End The Stigma!
Lady Gaga and Bradley Cooper did a masterful remake of “A Star is Born”, now in theaters. We highly…
Dr. Sanjay Gupta on CNN: “Ketamine offers lifeline for people with severe depression, suicidal thoughts”
In this post, a Wisconsin man who had been on the brink of suicide, told CNN’s Sanjay Gupta how…
The Resurgence of Psychedelics in Medicine
There has been a flurry of articles in the media recently touting the successful use of psychedelics in medicine.…
Ketamine Infusions Provide Effective Relief for Severe Chronic Headache
Medical research is revealing more and more applications for ketamine, the old drug being used in new ways. Just…
New Insight Into How Ketamine Works in Depression
Ketamine exerts an initial antidepressant effect by blocking the N-methyl-D-aspartate receptor (NMDAR), and the ketamine metabolite hydroxynorketamine (HNK) may extend…